Multiple sclerosis and Upper respiratory tract inflammation
Summary:
Upper respiratory tract inflammation is found among people with Multiple sclerosis, especially for people who are male, 30-39 old.
The study analyzes which people have Upper respiratory tract inflammation with Multiple sclerosis. It is created by eHealthMe based on reports of 13 people who have Multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Multiple sclerosis?
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,086 drugs and 1,363 conditions by eHealthMe. Check the latest studies of Multiple sclerosis.
What is Upper respiratory tract inflammation?
Upper respiratory tract inflammation is found to be associated with 367 drugs and 582 conditions by eHealthMe. Check the latest studies of Upper respiratory tract inflammation.
13 people who have Multiple Sclerosis and Upper Respiratory Tract Inflammation are studied.

Gender of people who have Multiple Sclerosis and experienced Upper Respiratory Tract Inflammation *:
- female: 38.46 %
- male: 61.54 %
Age of people who have Multiple Sclerosis and experienced Upper Respiratory Tract Inflammation *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 10 %
- 30-39: 40 %
- 40-49: 30 %
- 50-59: 10 %
- 60+: 10 %
Common co-existing conditions for these people *:
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 23.08%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 2 people, 15.38%
- Joint Pain: 2 people, 15.38%
- Thyroiditis Chronic (long lasting inflammation of thyroid gland): 1 person, 7.69%
- Stress And Anxiety: 1 person, 7.69%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
- Pain: 1 person, 7.69%
- Osteoporosis (bones weak and more likely to break): 1 person, 7.69%
- Oesophageal Varices Haemorrhage (bleeding from extremely dilated sub-mucosal veins in the lower third of the oesophagus): 1 person, 7.69%
- Gastritis (inflammation of stomach): 1 person, 7.69%
Common drugs taken by these people *:
- Gilenya: 4 people, 30.77%
- Synthroid: 3 people, 23.08%
- Xanax: 3 people, 23.08%
- Advair Diskus 100/50: 3 people, 23.08%
- Prednisone: 3 people, 23.08%
- Extavia: 3 people, 23.08%
- Famotidine: 2 people, 15.38%
- Solu-Medrol: 2 people, 15.38%
- Betaseron: 2 people, 15.38%
- Avonex: 2 people, 15.38%
Common symptoms for these people *:
- Influenza Like Illness: 4 people, 30.77%
- Headache (pain in head): 4 people, 30.77%
- Lymphocyte Count Decreased: 4 people, 30.77%
- Concomitant Disease Aggravated (advanced due to some of accompanying): 3 people, 23.08%
- Sinus Polyp (abnormal tissue growths that grow inside the nasal passages and sinuses): 3 people, 23.08%
- Dyspnea (difficult or laboured breathing): 3 people, 23.08%
- Pulmonary Congestion (congestion in the lungs): 3 people, 23.08%
- Blood Thyroid Stimulating Hormone Increased: 3 people, 23.08%
- Rickets (softening of bones): 3 people, 23.08%
- Sinobronchitis (long lasting paranasal sinusitis with repeated bronchitis): 3 people, 23.08%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Upper respiratory tract inflammation?
- Check whether Upper respiratory tract inflammation is associated with a drug or a conditionRelated publications that referenced our studies
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
- Christopher KL, Elner VM, Demirci H, "Conjunctival Lymphoma in a Patient on Fingolimod for Relapsing-Remitting Multiple Sclerosis", Ophthalmic Plastic & Reconstructive Surgery, 2017 May .
- Christopher, K. L., Elner, V. M., & Demirci, H. , "Conjunctival lymphoma in a patient on fingolimod for relapsing-remitting multiple sclerosis", Ophthalmic plastic and reconstructive surgery , 2014 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Multiple sclerosis (799,637 reports)
- Upper respiratory tract inflammation (3,100 reports)
All the drugs that are associated with Upper respiratory tract inflammation:
- Upper respiratory tract inflammation (367 drugs)
All the conditions that are associated with Upper respiratory tract inflammation:
- Upper respiratory tract inflammation (582 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Upper respiratory tract inflammation and Multiple sclerosis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Clofarabine and Busulfex - 6 seconds ago
- Could Solu-Cortef cause Small Intestinal Perforation? - 6 seconds ago
- Herpes Zoster and drugs of ingredients of nitroglycerin - 6 seconds ago
- Could Temaz cause Systemic Inflammatory Response Syndrome? - 10 seconds ago
- Could Basaglar cause The Flu? - 24 seconds ago
- Drug interactions of Zide and Odefsey - 24 seconds ago
- Novolog and Hctz drug interactions for men aged 60+ - 32 seconds ago
- Symbicort and Ventilatory Failure for Men aged 40-49 - 34 seconds ago
- Symbicort and Respiratory Failure for Men aged 40-49 - 34 seconds ago
- Symbicort and Acidosis - Respiratory for Men aged 40-49 - 34 seconds ago